Document is current
Any future updates will be listed below
-
Authors
Dharnidharka, Vikas R. https://orcid.org/0000-0001-8000-1385
Scobell, Rebecca R.
Kallash, Mahmoud
Davies, Amy J. Goodwin
Marchesani, Nicole
Maltenfort, Mitchell G.
Walther, Leslie
Kelton, Megan
Bock, Margret
Blanchette, Eliza
Stone, Hillarey K.
Gluck, Caroline
Hullekes, Frank
Riella, Leonardo V.
Smoyer, William E.
Mitsnefes, Mark
Dixon, Bradley P.
Flynn, Joseph T.
Somers, Michael J. G.
Forrest, Christopher B.
Furth, Susan
Denburg, Michelle R.
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (1306-01556)
Foundation for the National Institutes of Health (P50 DK1147786)
- License Information
-
More Information
Article History
Received: 10 January 2024
Revised: 17 June 2024
Accepted: 18 June 2024
First Online: 13 July 2024
Declarations
:
: Dharnidharka: Research grants: CareDx, NIAID, NCI, NIDDK; Denburg: Research grant: Mallinckrodt; Dixon: Consultancy – Apellis Pharmaceuticals, Alexion, Astra Zeneca Rare Disease, Novartis Pharmaceuticals; Smoyer: Consultancy – USC CTSI External Advisory Board, UCLA CCTS External Advisory Board, NephCure Kidney International Board; Funding – NIDDK; Riella: Investigator-initiated research from BMS, CareDx, Visterra; Federal funding from NIH and DOD; Industry-sponsored research Natera; Funding by Wellcome Leap. All other authors have no conflicts of interest to disclose.
